phase 2_initiation

National Cancer Institute US — cyclophosphamide (Phase II Trial Initiation)

April 27, 2026cyclophosphamideupdated 2mo ago

community read0 votes

Therapy area: Oncology. Indication: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?